This Week in PLOS Medicine: Smoking licenses; Neonatal care; Liver function in sepsis & more
Five new articles published this week in PLOS Medicine, including a Debate series and a new Research Article with a related Perspective.
In a PLOS Medicine Debate, Simon Chapman lays out a case for a smoker’s license designed to limit access to tobacco products and encourage cessation, and Jeff Collin argues against the proposal for a smoker’s license, saying that it is strategically flawed and ethically unsound.
Based upon an expert survey and consensus method, Sabine Gabrysch and colleagues recommend new signal functions to monitor and track facilities’ provision of routine and emergency newborn care.
Rosalind Howes and colleagues present a map of glucose-6-phosphate dehydrogenase deficiency prevalence and severity. Individuals with the deficiency are at risk of mild to severe hemolysis when taking the antimalarial primaquine.
Experimental studies in a rat model of fecal peritonitis conducted by Michael Bauer and colleagues show that in this model, changes in liver function occur early in the development of sepsis, with potential implications for prognosis and development of new therapeutic approaches. In an accompanying Perspective, John Marshall discusses the new research and says it can fundamentally change our understanding of this common clinical problem.
Remember you can comment on, annotate and rate any PLOS Medicine article and see the views, citations and other indications of impact of an article on that articles metrics tab.
Most important above all is to inform every smoker if he or she is positive for Oncological Terrain, Hypertensive, ATS, Dislipidemic, diabetic Constitutions.